Complain about a product or service

Gero Vita Settles Federal Charges

June 8, 2005
Gero Vita International has settled Federal Trade Commission charges that it violated federal law by claiming that its products could cure or treat numerous illnesses and conditions, including asthma, diabetes, Alzheimer’s disease, overweight, and sexual dysfunction.

Gero Vita • Gero Vita Promoter Settles FTC Charges • Gero Vita Promoter Fined $4.5 Million • Gero Vita Settles Federal Charges • Gero Vita Head Got Clinton Pardon • Gero Vita, Theraceuticals Use Deceptive Advertising, FTC Charges • Consumer Complaints

The defendants are barred from making misleading claims about their products and are required to pay monetary judgments totaling $605,000.

In May 2003, the FTC filed a complaint against the company and several of its officers and affiliates alleging that they deceptively marketed five dietary supplements, including:

• "Lung Support Formula," a dietary supplement that purportedly cured nearly all breathing and respiratory problems, including asthma, emphysema, and smoking-related damage;
• "Antibetic Pancreas Tonic," an herbal supplement that purportedly treated or cured both Type I and Type II diabetes;
• "G.H.3," also known as :Theraceuticals GH3 Romanian Youth Formula," marketed as an anti-aging product that could reverse and prevent Alzheimer’s disease and other forms of dementia;
• "Chitoplex," a chitosan-based weight-loss product that purportedly enabled users to lose weight without diet or exercise; and
• "Testerex," a yohimbe product touted as effective in treating 62-95 percent of cases of impotence and erectle dysfunction.

The orders prohibit the settling defendants from making deceptive claims for the products that were the subject of the 2003 complaint and require them to include a safety warning on any product containing yohimbe, an herb that can raise blood pressure in some individuals.

The orders prohibit the defendants from making unsubstantiated disease treatment claims for any food, drug, or dietary supplement, and require that any endorser used by the defendants must actually have the represented expertise and a reasonable basis for the endorsement.

The corporate orders contain a $30 million judgment, suspended upon payment of $540,000 in installments over 18 months, based on the corporate defendants’ inability to pay. The corporate defendants will be held liable for the entire $30 million if it is found that they misrepresented their financial condition or if it is found that defendant Braswell has acquired any ownership interest in, or control over, any corporate defendant, or becomes involved in any business relationship with, or receives any payment from, any corporate defendant.

Other defendants include A. Glenn Braswell; his companies, JOL Management, G.B. Data Systems, Gero Vita International, and Theraceuticals, Inc.; and Ron Tepper, a corporate officer and director.

The orders against individual defendants Tepper and Lawrence contain monetary judgments of $40,000 and $25,000 respectively, and avalanche clauses of $500,000 that will become due if it is found that they misrepresented their financial status. Finally, the orders require the settling defendants to cooperate in the ongoing litigation against the remaining defendants.

The FTC’s complaint was later amended to name six additional defendants: Health Quest Publications, Inc., G.B. Data Systems, Inc. (Canada), Halsey Holdings LLC, Ronald Lawrence, M.D., Ph.D., Hans Kugler, Ph.D., and Chase Revel. Lawrence and Kugler appeared in the defendants’ ads as expert endorsers, and Revel helped write some of the ads. The settlements announced today concern JOL Management, G.B. Data Systems, Gero Vita International, Health Quest Publications, Halsey Holdings, Tepper, and Lawrence. The case against Braswell, Kugler, and Revel is still pending.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share		Follow us on Twitter.

Back to the top |